Clinical data imminent!

Immuron CEO Steve Lydeamore speaks about the clinical work it is doing with IMM-124e and IMM-529, its involvement with the Uniformed Services University and the Naval Medical Research Command, and the commercial opportunity for Travelan.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.